help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ciaraldi, T. P.
Right arrow Articles by Yen, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ciaraldi, T. P.
Right arrow Articles by Yen, S. S.

Journal of Clinical Endocrinology & Metabolism, Vol 75, 577-583, Copyright © 1992 by Endocrine Society

ARTICLES

Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

TP Ciaraldi, A el-Roeiy, Z Madar, D Reichart, JM Olefsky and SS Yen
Department of Medicine, University of California, La Jolla 92093.

Insulin resistance is a predominant feature in women with polycystic ovarian syndrome (PCO). The cellular mechanisms for this insulin resistance have not been defined. In this study, major steps in the insulin action cascade, receptor binding, kinase activity, and glucose transport activity were evaluated in isolated adipocytes prepared from PCO subjects (n = 8) without acanthosis nigricans and in a group of age and weight-matched controls [normal cycling (NC) n = 8]. The PCO group was hyperinsulinemic and displayed elevated insulin responses to an iv glucose load. The binding of 125I-insulin to adipocytes was similar in cells from PCO and NC subjects. In PCO, autophosphorylation of the insulin receptor-subunit in the absence of insulin was normal but a significant decrease (30% below control) in maximal insulin stimulated autophosphorylation was observed. However, receptor kinase activity measured against the exogenous substrate poly glu:tyr (4:1) was normal. Cells from PCO subjects transported glucose at the same rate, in both the absence and presence of a maximal insulin concentration, as those from NC subjects. Strikingly, there was a large rightward shift in the insulin dose-response curve for transport stimulation in PCO cells (EC50 = 87 +/- 14 pmol in NC vs. 757 +/- 138 in PCO, P less than 0.0005); 8-fold greater insulin concentrations were required to attain comparable glucose transport rates in cells from PCO against NC. In conclusion, our results suggest that insulin resistance in PCO, as assessed in the adipocyte, is accompanied by normal function of insulin receptors, but involves a novel postreceptor defect in the insulin signal transduction chain between the receptor kinase and glucose transport.


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
J. H. Page, J. Ma, K. M. Rexrode, N. Rifai, J. E. Manson, and S. E. Hankinson
Plasma Dehydroepiandrosterone and Risk of Myocardial Infarction in Women
Clin. Chem., July 1, 2008; 54(7): 1190 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Jensterle, A. Janez, B. Mlinar, J. Marc, J. Prezelj, and M. Pfeifer
Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
Eur. J. Endocrinol., June 1, 2008; 158(6): 793 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
S. Chakrabarty and M. Nagamani
Peripubertal Hyperinsulinemia Upregulates Phosphatidylinositol 3-Kinase/Akt Pathway in Rat Ovaries
Reproductive Sciences, March 1, 2008; 15(3): 274 - 284.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
K.-M. Seow, C.-C. Juan, Y.-P. Hsu, J.-L. Hwang, L.-W. Huang, and L.-T. Ho
Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery
Hum. Reprod., April 1, 2007; 22(4): 1003 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
A Corbould
Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women
J. Endocrinol., March 1, 2007; 192(3): 585 - 594.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Corbould, H. Zhao, S. Mirzoeva, F. Aird, and A. Dunaif
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Diabetes, March 1, 2006; 55(3): 751 - 759.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
E. Lystedt, H. Westergren, J. Brynhildsen, L. Lindh-Astrand, J. Gustavsson, F. H Nystrom, M. Hammar, and P. Stralfors
Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness
Eur. J. Endocrinol., December 1, 2005; 153(6): 831 - 835.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinos, F. Fabregues, J. Herrero, and (Reproductive Endocrinology Interest Group of the
Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2005; 11(4): 375 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Corbould, Y.-B. Kim, J. F. Youngren, C. Pender, B. B. Kahn, A. Lee, and A. Dunaif
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1047 - E1054.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Apridonidze, P. A. Essah, M. J. Iuorno, and J. E. Nestler
Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1929 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Soderlund, P. Canto, S. Carranza-Lira, and J.P. Mendez
No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome
Hum. Reprod., April 1, 2005; 20(4): 965 - 969.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
V. L. Nelson-Degrave, J. K. Wickenheisser, K. L. Hendricks, T. Asano, M. Fujishiro, R. S. Legro, S. R. Kimball, J. F. Strauss III, and J. M. McAllister
Alterations in Mitogen-Activated Protein Kinase Kinase and Extracellular Regulated Kinase Signaling in Theca Cells Contribute to Excessive Androgen Production in Polycystic Ovary Syndrome
Mol. Endocrinol., February 1, 2005; 19(2): 379 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A.S. Sonmez, L. Yasar, K. Savan, S. Koc, J. Ozcan, A. Toklar, F. Yazicioglu, A. Akgun, and N. Sut
Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome
Hum. Reprod., January 1, 2005; 20(1): 175 - 179.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Mioni, S. Chiarelli, N. Xamin, L. Zuliani, M. Granzotto, B. Mozzanega, P. Maffei, C. Martini, S. Blandamura, N. Sicolo, et al.
Evidence for the Presence of Glucose Transporter 4 in the Endometrium and Its Regulation in Polycystic Ovary Syndrome Patients
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4089 - 4096.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
H-W. Yen, A.J. Jakimiuk, I. Munir, and D.A. Magoffin
Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries
Mol. Hum. Reprod., July 1, 2004; 10(7): 473 - 479.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Carbunaru, P. Prasad, B. Scoccia, P. Shea, N. Hopwood, F. Ziai, Y. T. Chang, S. E. Myers, J. I. Mason, and S. Pang
The Hormonal Phenotype of Nonclassic 3{beta}-Hydroxysteroid Dehydrogenase (HSD3B) Deficiency in Hyperandrogenic Females Is Associated with Insulin-Resistant Polycystic Ovary Syndrome and Is Not a Variant of Inherited HSD3B2 Deficiency
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 783 - 794.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. Munir, H.-W. Yen, D. H. Geller, D. Torbati, R. M. Bierden, S. R. Weitsman, S. K. Agarwal, and D. A. Magoffin
Insulin Augmentation of 17{alpha}-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase But Not Extracellular Signal-Regulated Kinase-1/2 in Human Ovarian Theca Cells
Endocrinology, January 1, 2004; 145(1): 175 - 183.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., G. Matarese, S. Di Biase, S. Palomba, D. Labella, V. Sanna, S. Savastano, F. Zullo, A. Colao, and G. Lombardi
Exon 6 and 2 Peroxisome Proliferator-Activated Receptor-{gamma} Polymorphisms in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5887 - 5892.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. De Leo, A. la Marca, and F. Petraglia
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Endocr. Rev., October 1, 2003; 24(5): 633 - 667.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Cagnacci, A. M. Paoletti, A. Renzi, M. Orru, M. Pilloni, G. B. Melis, and A. Volpe
Glucose Metabolism and Insulin Resistance in Women with Polycystic Ovary Syndrome during Therapy with Oral Contraceptives Containing Cyproterone Acetate or Desogestrel
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3621 - 3625.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, J.-P. Baillargeon, M. J. Iuorno, D. J. Jakubowicz, and J. E. Nestler
A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1927 - 1932.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
S. S. George, K. George, C. Irwin, V. Job, R. Selvakumar, V. Jeyaseelan, and M.S. Seshadri
Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial
Hum. Reprod., February 1, 2003; 18(2): 299 - 304.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Morin-Papunen, I. Vauhkonen, R. Koivunen, A. Ruokonen, H. Martikainen, and J. S. Tapanainen
Metformin Versus Ethinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 148 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Diabetes Care, January 1, 2003; 26(90001): s5 - 20.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Azziz
Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4085 - 4087.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Li, J. F. Youngren, A. Dunaif, I. D. Goldfine, B. A. Maddux, B. B. Zhang, and J. L. Evans
Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4088 - 4093.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, A. E. Calogero, M. Farina, V. De Leo, A. La Marca, and A. Cianci
Clinical, endocrine and metabolic effects of acarbose, an {alpha}-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
Hum. Reprod., October 1, 2001; 16(10): 2066 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Dunaif, X. Wu, A. Lee, and E. Diamanti-Kandarakis
Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)
Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E392 - E399.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M.W. Elting, T.J.M. Korsen, P.D. Bezemer, and J. Schoemaker
Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population
Hum. Reprod., March 1, 2001; 16(3): 556 - 560.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. J. Marsden, A. P. Murdoch, and R. Taylor
Adipocyte insulin action in hypogonadotrophic hypogonadism
Hum. Reprod., August 1, 2000; 15(8): 1672 - 1678.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. C. Morin-Papunen, I. Vauhkonen, R. M. Koivunen, A. Ruokonen, and J. S. Tapanainen
Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome
Hum. Reprod., June 1, 2000; 15(6): 1266 - 1274.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, V. De Leo, F. Galvani, A. La Marca, and A. Cianci
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia
Hum. Reprod., December 1, 1999; 14(12): 2951 - 2958.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. J.Marsden, A. P. Murdoch, and R. Taylor
Adipocyte insulin action following ovulation in polycystic ovarian syndrome
Hum. Reprod., September 1, 1999; 14(9): 2216 - 2222.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Urbanek, R. S. Legro, D. A. Driscoll, R. Azziz, D. A. Ehrmann, R. J. Norman, J. F. Strauss III, R. S. Spielman, and A. Dunaif
Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin
PNAS, July 20, 1999; 96(15): 8573 - 8578.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Cagnacci, A.M. Paoletti, S. Arangino, G.B. Melis, and A. Volpe
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
Hum. Reprod., April 1, 1999; 14(4): 893 - 897.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, A. R. Kunselman, W. C. Dodson, and A. Dunaif
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 165 - 169.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
A. Dunaif
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Endocr. Rev., December 1, 1997; 18(6): 774 - 800.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. E. Nestler and D. J. Jakubowicz
Lean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17{alpha} Activity and Serum Androgens
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4075 - 4079.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. A. Laughlin, A. J. Morales, and S. S. C. Yen
Serum Leptin Levels in Women with Polycystic Ovary Syndrome: The Role of Insulin Resistance/ Hyperinsulinemia
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1692 - 1696.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. P. Ciaraldi, A. J. Morales, M. G. Hickman, R. Odom-Ford, J. M. Olefsky, and S. S. C. Yen
Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1421 - 1425.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. J. Jakubowicz and J. E. Nestler
17{alpha}-Hydroxyprogesterone Responses to Leuprolide and Serum Androgens in Obese Women with and without Polycystic Ovary Syndrome after Dietary Weight Loss
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 556 - 560.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. E. Nestler and D. J. Jakubowicz
Decreases in Ovarian Cytochrome P450c17{alpha} Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
N. Engl. J. Med., August 29, 1996; 335(9): 617 - 623.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Franks
Polycystic Ovary Syndrome
N. Engl. J. Med., September 28, 1995; 333(13): 853 - 861.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society